Braveheart Bio, Inc. BRVE
IPO
NASDAQ
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -4.96% | -284.85% | |||
| Total Depreciation and Amortization | 50.00% | -- | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | -38.11% | 276.60% | |||
| Change in Net Operating Assets | -141.63% | 440.00% | |||
| Cash from Operations | -226.84% | -- | |||
| Capital Expenditure | 122.22% | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | 100.00% | -- | |||
| Cash from Investing | 100.26% | -- | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -9.92% | -- | |||
| Cash from Financing | 16,407.71% | -- | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 592.20% | -- | |||